Benjamin T. Kopp, MD, is a member of the Division of Pulmonary Medicine and a principal investigator for the Center for Microbial Pathogenesis. He is also a member of the Cystic Fibrosis Team and an Assistant Professor of Pediatrics for The Ohio State University College of Medicine. Dr. Kopp received his undergraduate degree from Miami University, Oxford, Ohio, and went to medical school at The Ohio State University College of Medicine. He completed his residency and fellowship in pediatric pulmonology at Nationwide Children’s Hospital. Dr. Kopp’s research interest involves therapies for cystic fibrosis including early disease mechanisms and improving clearance of chronic bacterial infections (b. cenocepacia).View CV »
Translational cystic fibrosis research focused on the immunologic control of Burkholderia cenocepacia infection.
Primarily interested in human macrophage control of these interactions.
Investigating therapies to improve the macrophage clearance of B. cenocepacia to prevent exaggerated inflammation and poor patient outcomes.
Biomarkers of inflammation in infants with CF.
Co-morbid conditions that impact inflammation in CF (secondhand smoke, depression.